医学
甲状腺机能正常
甲状腺
前瞻性队列研究
内科学
甲状腺疾病
甲状腺肿
甲状腺炎
胃肠病学
甲状腺切除术
抗甲状腺自身抗体
生活质量(医疗保健)
置信区间
自身抗体
免疫学
抗体
护理部
作者
Johannes Ott,Regina Promberger,F. Kober,N. Neuhold,Maria Tea,Sylvia Kirchengast,Martin Hermann
出处
期刊:Thyroid
[Mary Ann Liebert]
日期:2010-12-27
卷期号:21 (2): 161-167
被引量:158
标识
DOI:10.1089/thy.2010.0191
摘要
Hashimoto's thyroiditis (HT) is a common disease, and is the most prevalent cause of hypothyroidism. Symptoms and diseases associated with HT are considered to be caused by hypothyroidism. We hypothesized that higher antithyroperoxidase (anti-TPO) antibody levels would be associated with an increased symptom load and a decreased quality of life in a female euthyroid patient collective.In a prospective cohort study 426 consecutive euthyroid female patients undergoing thyroid surgery for benign thyroid disease were included. Main outcome measures were preoperative anti-TPO levels, a symptom questionnaire and the SF-36 questionnaire, and lymphocytic infiltration of the thyroid tissue as evaluated by histology.Histology revealed HT in 28/426 (6.6%) subjects. To maximize the sum of the predictive values, a cut-off point for anti-TPO of 121.0 IU/mL was calculated (sensitivity 93.3% [95% confidence interval: 77.9%-99.0%]; specificity 94.7% [95% confidence interval: 92.0%-96.7%]) to predict the presence of histological signs of HT. The mean number of reported symptoms was significantly higher in patients with anti-TPO levels >121.0 IU/mL than in the other group (6.7 ± 2.5 vs. 4.1 ± 2.8; p < 0.001). There were no differences in preoperative thyroid-stimulating hormone levels (1.7 ± 1.3 vs. 1.5 ± 1.4 μU/mL, respectively; p = 0.155). Chronic fatigue, dry hair, chronic irritability, chronic nervousness, a history of breast cancer and early miscarriage, and lower quality-of-life levels were significantly associated with anti-TPO levels exceeding the cut-off point (p < 0.05).Women with HT suffer from a high symptom load. Hypothyroidism is only a contributing factor to the development of associated conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI